ZURICH (Reuters) - Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said on Thursday.
AUSTIN, Texas (Reuters) - Texas plans to block about $3 million in Medicaid funding for Planned Parenthood operations in the state, a legal document obtained on Wednesday showed, a move the reproductive healthcare group said could affect nearly 11,000 low-income people.
RALEIGH, N.C. (Reuters) - North Carolina's Republican-controlled legislature on Wednesday rejected a bid to repeal a state law restricting bathroom access for transgender people, which has drawn months of protests and boycotts by opponents decrying the measure as discriminatory.
NEW YORK (Reuters) - Roughly 6.4 million consumers signed up for Obamacare insurance on Healthcare.gov from Nov. 1 to Dec. 19 indicating "clear demand for quality, affordable coverage," the U.S. government said on Wednesday.
BEIJING (Reuters) - China has found two more cases of human bird flu infection, bringing this week's total to three and stoking fears the deadly virus could spread at a time when other Asian nations are battling to control outbreaks of the disease.
(Reuters) - Inovio Pharmaceuticals Inc said its experimental Zika vaccine induced robust immune responses in an early-stage study in human volunteers who have not been infected with the virus.
SAO PAULO (Reuters) - Belgium's Ontex Group NV said on Thursday it is in advanced talks to buy the diapers business of Hypermarcas SA , Brazil's most diversified pharmaceutical firm.
NEW YORK (Reuters) - The surprise selection of Michel Vounatsos to run Biogen Inc signals a shift toward a more commercial management focus after years of targeting ambitious scientific gains, and likely keeps the U.S. biotech in play as a takeover target.
BOGOTA (Reuters) - Colombia's government has lowered the price of Novartis cancer drug imatinib by nearly half in a bid to cut healthcare costs after failed price negotiations with the Swiss company.
No comments:
Post a Comment